A Dose Escalation and Dose Expansion Study of NOX66 in the Treatment of COVID-19
Clinical trial NCT04555213 · COMPLETED
Trial details
- NCT number
- NCT04555213
- Sponsor
- Noxopharm Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-30
- Primary completion
- 2021-08-10
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.